Abstract
Aim: Many governments in East and Southeast Asia responded promptly and effectively at the onset of the COVID-19 pandemic. Synthesizing and analyzing these responses is vital for disease control evidence-based policymaking. Methods: An extensive review of COVID-19 control measures was conducted in selected Asian countries and subregions, including Mainland China, Hong Kong, Taiwan, South Korea, Singapore, Japan, and Vietnam from 1 January to 30 May 2020. Control measures were categorized into administrative, public health, and health system measures. To evaluate the stringency and timeliness of responses, we developed two indices: the Initial Response Index (IRI) and the Modified Stringency Index (MSI), which builds on the Oxford COVID-19 Government Response Tracker (OxCGRT). Results: Comprehensive administrative, public health, and health system control measures were implemented at the onset of the outbreak. Despite variations in package components, the stringency of control measures across the study sites increased with the acceleration of the outbreak, with public health control measures implemented the most stringently. Variations in daily average MSI scores are observed, with Mainland China scoring the highest (74.2), followed by Singapore (67.4), Vietnam (66.8), Hong Kong (66.2), South Korea (62.3), Taiwan (52.1), and Japan (50.3). Variations in IRI scores depicting timeliness were higher: Hong Kong, Taiwan, Vietnam, and Singapore acted faster (IRI > 50.0), while Japan (42.4) and Mainland China (4.2) followed. Conclusions: Timely setting of stringency of the control measures, especially public health measures, at dynamically high levels is key to optimally controlling outbreaks.
Funder
World Bank Group
Ministry of Finance, Saudi Arabia
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference102 articles.
1. Coronavirus Pandemic (COVID-19). Our World Data. Published Online 4 March 2020https://ourworldindata.org/coronavirus
2. COVID-19 Situation Update Worldwide, As of Week 50 2020. European Centre for Disease Prevention and Controlhttps://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases
3. SARS-CoV-2 Variants. World Health Organizationhttp://www.who.int/csr/don/31-december-2020-sars-cov2-variants/en/
4. Tracking SARS-CoV-2 Variantshttps://www.who.int/en/activities/tracking-SARS-CoV-2-variants/
5. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant